- Home
- PROK vs FBYD Comparison
PROK vs FBYD Comparison
Compare PROK & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FBYD
- Stock Information
- Founded
- PROK 2015
- FBYD 2021
- Country
- PROK United States
- FBYD United States
- Employees
- PROK N/A
- FBYD N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FBYD
- Sector
- PROK Health Care
- FBYD
- Exchange
- PROK Nasdaq
- FBYD Nasdaq
- Market Cap
- PROK 417.1M
- FBYD 468.0M
- IPO Year
- PROK N/A
- FBYD N/A
- Fundamental
- Price
- PROK $2.97
- FBYD $10.38
- Analyst Decision
- PROK Strong Buy
- FBYD
- Analyst Count
- PROK 4
- FBYD 0
- Target Price
- PROK $6.25
- FBYD N/A
- AVG Volume (30 Days)
- PROK 2.1M
- FBYD 41.0K
- Earning Date
- PROK 11-11-2025
- FBYD 11-13-2025
- Dividend Yield
- PROK N/A
- FBYD N/A
- EPS Growth
- PROK N/A
- FBYD N/A
- EPS
- PROK N/A
- FBYD 0.43
- Revenue
- PROK $527,000.00
- FBYD $7,688,000.00
- Revenue This Year
- PROK $427.89
- FBYD N/A
- Revenue Next Year
- PROK N/A
- FBYD N/A
- P/E Ratio
- PROK N/A
- FBYD $24.30
- Revenue Growth
- PROK N/A
- FBYD 9.17
- 52 Week Low
- PROK $0.46
- FBYD $3.62
- 52 Week High
- PROK $7.13
- FBYD $16.35
- Technical
- Relative Strength Index (RSI)
- PROK 55.05
- FBYD 44.38
- Support Level
- PROK $2.80
- FBYD $10.32
- Resistance Level
- PROK $3.28
- FBYD $13.30
- Average True Range (ATR)
- PROK 0.27
- FBYD 0.94
- MACD
- PROK 0.01
- FBYD -0.35
- Stochastic Oscillator
- PROK 57.52
- FBYD 12.93
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.